CaviSense is a medical device company that provides an innovative, FDA-registered toothpick tool designed to detect early-stage cavities by sensing biofilm pH, enabling clinicians to identify and address tooth decay before it becomes irreversible.
CaviSense is a medical device company that has developed a patented, FDA-registered toothpick designed for the early detection and monitoring of tooth cavities. Based on technology originating from Harvard and Tufts universities, the device utilizes localized pH-sensing material to identify high-caries-risk biofilm acids. When the toothpick tip comes into contact with a tooth surface experiencing active demineralization, defined by a pH level below 5.5, it changes color from purple to yellow within 10 seconds. This non-invasive, radiation-free tool is intended to help clinicians and patients identify lesions at early stages when they are still potentially reversible, providing an alternative or supplement to traditional diagnostic methods like X-rays.
The technology is particularly significant for its ability to test interproximal spaces, pits, and fissures, enabling more efficient early intervention in dental care. It is supported by a mobile application, the CaviSense Pro app, which assists clinicians in magnifying results, documenting tests, and tracking treatment plans. By providing real-time data, the system empowers dental professionals to optimize patient care plans and allows patients to take a more active role in their oral health management. CaviSense aims to address the prevalence of dental cavities as a chronic disease by shifting the diagnostic focus toward early, actionable detection before significant tooth decay occurs.